UPC Analytics
DEEN
Übersicht · Eingereicht: 5. Jan. 2026

UPC_CoA_2/2026

AUTOMATED MANAGEMENT OF CLINICAL MODIFICATIONS TO TREATMENT PLANS USING THREE-DIMENSIONAL CONTROLS

BerufungenHauptberufungCourt of AppealAppealCase Closed
ÜbersichtEntscheidungenZitateDokumenteZeitverlauf
Parteien

Kläger

  • Align Technology, Inc.
Vertreter: Agathe Michel-De Cazotte (Carpmaels & Ransford LLP)

Beklagte

  • Angelalign Technology Inc.
  • Angelalign France Technology SASU
  • Europe Angelalign Technology B.V.
  • Angelalign Technology (Germany) GmbH
  • Italy Angelalign Technology S.R.L.
  • Shanghai EA Medical Instruments Co., Ltd.
Vertreter: Felix Beck (Arnold Ruess Rechtsanwälte Part mbB)
Richter
  • Rian Kalden
Patente
  • EP4346690
  • EP 4 346 690
CPC-Codes: G16H50/50, A61C7/08, A61C9/004, A61C13/0004, G16H40/67, G16H30/20, G16H30/40, G16H50/70, A61C13/0019, B33Y80/00, A61C13/0006, G16H20/30…

Sektor: Healthcare Informatics

Ausgang
Abgewiesen
Eingereicht: 5. Jan. 2026
Erste Entscheidung: 6. Jan. 2026
Sprache: English

The standing judge of the Court of Appeal (Rian Kalden) dismissed Angelalign's request for discretionary review (R. 220.3 RoP) of the Düsseldorf Local Division's procedural order of 16 December 2025 (which had disregarded certain non-infringement arguments and an exhibit in the provisional measures proceedings concerning EP 4 346 690). The request was dismissed as Angelalign failed to provide sufficiently specific references to support its claim that the impugned order was 'manifestly erroneous'.

Im UPC-Register öffnen